Free Trial

agilon health (NYSE:AGL) Shares Gap Up on Earnings Beat

agilon health logo with Medical background

agilon health, inc. (NYSE:AGL - Get Free Report)'s share price gapped up before the market opened on Wednesday following a stronger than expected earnings report. The stock had previously closed at $4.46, but opened at $4.71. agilon health shares last traded at $3.58, with a volume of 1,451,565 shares trading hands.

The company reported $0.03 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.01) by $0.04. The business had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.50 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The company's revenue for the quarter was down 4.5% on a year-over-year basis. During the same quarter in the prior year, the business posted ($0.02) EPS.

Analyst Upgrades and Downgrades

AGL has been the subject of a number of research reports. Robert W. Baird decreased their price objective on agilon health from $6.00 to $5.00 and set a "neutral" rating for the company in a research report on Tuesday, April 15th. JMP Securities reissued a "market perform" rating on shares of agilon health in a research note on Monday, April 28th. Royal Bank of Canada lifted their price objective on shares of agilon health from $3.00 to $3.50 and gave the company an "outperform" rating in a research note on Wednesday, February 26th. Citigroup raised shares of agilon health from a "neutral" rating to a "buy" rating and lifted their price target for the company from $3.25 to $5.00 in a research report on Friday, April 25th. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of agilon health in a research report on Friday, March 21st. Two investment analysts have rated the stock with a sell rating, thirteen have issued a hold rating and four have given a buy rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $4.89.

Check Out Our Latest Stock Report on agilon health

Institutional Trading of agilon health

A number of hedge funds have recently made changes to their positions in the company. Nisa Investment Advisors LLC raised its stake in agilon health by 244.9% during the first quarter. Nisa Investment Advisors LLC now owns 9,553 shares of the company's stock worth $41,000 after buying an additional 6,783 shares during the last quarter. Oak Thistle LLC purchased a new stake in shares of agilon health in the fourth quarter worth approximately $25,000. Ieq Capital LLC bought a new stake in shares of agilon health in the 4th quarter worth $26,000. Signaturefd LLC increased its position in shares of agilon health by 143.0% during the fourth quarter. Signaturefd LLC now owns 14,388 shares of the company's stock valued at $27,000 after acquiring an additional 8,467 shares during the last quarter. Finally, Ridgecrest Wealth Partners LLC purchased a new position in shares of agilon health in the 1st quarter worth about $65,000.

agilon health Trading Down 10.9 %

The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. The firm has a market capitalization of $1.19 billion, a P/E ratio of -3.05 and a beta of 0.38. The firm has a fifty day simple moving average of $4.27 and a two-hundred day simple moving average of $3.19.

agilon health Company Profile

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

See Also

Should You Invest $1,000 in agilon health Right Now?

Before you consider agilon health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.

While agilon health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025
3 Sectors With Massive Momentum You Can’t Afford to Miss

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines